Teva's Respiratory Drugs Contribute 11% to Specialty Medicines
Teva Pharmaceuticals and IBM Partner to Build Global e-Health Solutions on the IBM Watson Health Cloud
Teva Announces FDA approval of AirDuo® Digihaler™
Teva's Unorthodox Strategy For The Respiratory Market — Will It Work
Teva Announces FDA Approval of First and Only Digital Inhaler with Built-In Sensors – ProAir® Digihaler™ | SnackSafely.com
Teva Announces FDA Approval of 2 New Respiclick Maintenance Inhalers - Drug Discovery and Development
Teva Launches 2 New Digital Maintenance Inhalers
Teva Releases AirDuo RespiClick plus Generic for Asthma | RT
Teva Pharmaceuticals receives European approval for Spiromax inhalers - Drug Delivery Business
Teva's ProAir Digihaler FDA Approved to Monitor Asthma and COPD Treatment - Basel St 5, Petah Tikva, Israel
Teva Seeks To Simplify With Canadian Inhalers :: Generics Bulletin
Perrigo, Catalent get generic of Teva inhaler approved on 4th go-round | Fierce Pharma
Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder
Teva Pharmaceuticals buys smart inhaler company Gecko Health Innovations | MobiHealthNews
Teva Pharmaceuticals on Twitter: "Are you attending #AAAAI21? Be sure to visit our virtual booth to learn more about Teva's work to improve care for #asthma and #COPD patients. https://t.co/2vgkja3Zli https://t.co/ybwPHkAdOX" /
Strategy for inhaled corticosteroid use leads to better asthma outcomes, according to national study of Black and Latinx patients | UIC Today
Teva Develops First FDA-Approved Digitally-Integrated Inhaler
Teva's Advair rival joins the hopefuls gunning for GSK's blockbuster sales | Fierce Pharma
Anything but Generic: A map for Selling to Teva Pharmaceuticals
Teva Canada Announces Availability of Aermony RespiClick™, an Innovative New Device for the Treatment of Bronchial Asthma | Business Wire
Teva Announces Unique Collaboration with HealthSnap to Expand the Reach of its Respiratory Digital Health Platform
Teva's severe eosinophilic asthma drug Cinqaero wins EU approval
Teva Pharmaceuticals Prepares for Upcoming Launch of Daily Maintenance Asthma Medication | Asthma and Allergy Foundation of America
Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder | Business Wire
Teva and Other Generic Drugmakers Inflated Prices Up to 1,000%, State Prosecutors Say - The New York Times
